CXS
Click for more information
0.00% 70.0¢ chemgenex pharmaceuticals ltd

re: Ann: Complete Response Letter from FDA Re... Good percentage...

  1. practisingaccountant
    9,543 Posts.
    lightbulb Created with Sketch. 17
    clock Created with Sketch.
    12/04/10
    20:09
    Post #: 6563049
    re: Ann: Complete Response Letter from FDA Re... Good percentage of buyers seem to have been daytraders. Rally was over in less than 10 minutes!!!

    Interesting to see if this causes RBS to revise its price target. RBS downgraded its price target from $1.51 a share to 45c after the initial news on 23/3/2010. In the absence of other factors or analyst reports, this single downgrade appears to explain why the share price had not moved much further north of 45c. Interesting to see if the news today forces RBS to revisit its rather arbitrary downgrade.
    CXS Price at posting: 47.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.